 Carcinoma, Renal Cell
"Carcinoma, Renal Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Descriptor ID |
D002292
|
| MeSH Number(s) |
C04.557.470.200.025.390 C04.588.945.947.535.160 C12.758.820.750.160 C12.777.419.473.160 C13.351.937.820.535.160 C13.351.968.419.473.160
|
| Concept/Terms |
Carcinoma, Renal Cell- Carcinoma, Renal Cell
- Carcinomas, Renal Cell
- Renal Cell Carcinomas
- Adenocarcinoma, Renal Cell
- Adenocarcinomas, Renal Cell
- Renal Cell Adenocarcinoma
- Renal Cell Adenocarcinomas
- Adenocarcinoma Of Kidney
- Adenocarcinoma Of Kidneys
- Kidney, Adenocarcinoma Of
- Kidneys, Adenocarcinoma Of
- Renal Cell Cancer
- Cancer, Renal Cell
- Cancers, Renal Cell
- Renal Cell Cancers
- Adenocarcinoma, Renal
- Adenocarcinomas, Renal
- Renal Adenocarcinoma
- Renal Adenocarcinomas
- Nephroid Carcinoma
- Carcinoma, Nephroid
- Carcinomas, Nephroid
- Nephroid Carcinomas
- Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma- Clear Cell Renal Cell Carcinoma
- Grawitz Tumor
- Tumor, Grawitz
- Clear Cell Renal Carcinoma
- Carcinoma, Hypernephroid
- Carcinomas, Hypernephroid
- Hypernephroid Carcinoma
- Hypernephroid Carcinomas
- Hypernephroma
- Hypernephromas
Collecting Duct Carcinoma (Kidney)- Collecting Duct Carcinoma (Kidney)
- Carcinoma, Collecting Duct (Kidney)
- Carcinomas, Collecting Duct (Kidney)
- Collecting Duct Carcinomas (Kidney)
- Collecting Duct Carcinoma of the Kidney
- Renal Collecting Duct Carcinoma
- Collecting Duct Carcinoma
- Carcinoma, Collecting Duct
- Carcinomas, Collecting Duct
- Collecting Duct Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Renal Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Renal Cell".
This graph shows the total number of publications written about "Carcinoma, Renal Cell" by people in this website by year, and whether "Carcinoma, Renal Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2006 | 1 | 1 | 2 | | 2007 | 2 | 0 | 2 | | 2008 | 4 | 0 | 4 | | 2009 | 2 | 1 | 3 | | 2010 | 4 | 0 | 4 | | 2011 | 4 | 1 | 5 | | 2012 | 6 | 1 | 7 | | 2013 | 7 | 2 | 9 | | 2014 | 10 | 0 | 10 | | 2015 | 8 | 0 | 8 | | 2016 | 6 | 0 | 6 | | 2017 | 5 | 0 | 5 | | 2018 | 8 | 0 | 8 | | 2019 | 12 | 0 | 12 | | 2020 | 14 | 0 | 14 | | 2021 | 13 | 1 | 14 | | 2022 | 19 | 0 | 19 | | 2023 | 7 | 0 | 7 | | 2024 | 13 | 1 | 14 | | 2025 | 16 | 0 | 16 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Renal Cell" by people in Profiles.
-
Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol. 2026 Apr; 44(4):110979.
-
Kopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M. Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study. Cancer Immunol Immunother. 2025 Nov 14; 74(12):374.
-
Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M. Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study). Int J Cancer. 2026 Mar 01; 158(5):1396-1405.
-
Massari F, Rosellini M, Melichar B, Grande E, Bourlon MT, Li H, Fiala O, Park SH, Fita MJJ, Taha T, Molina-Cerrillo J, Santini D, de Liañ AG, Büttner T, Scagliarini S, Manneh Kopp R, Zeppellini A, Ghosn M, Conteduca V, Bölek H, Rizzo A, Ansari J, Mollica V, Zgura A, Filosa A, Yildirim A, Akova U, Monteiro FSM, Buti S, Soares A, Bilen MA, Ürün Y, Santoni M. Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study. JCO Glob Oncol. 2025 Oct; 11:e2500376.
-
Dabbas MR, Guer M, Musso G, Garofano G, Meagher MF, Puri D, Yuen KL, Capitanio U, Larcher A, Saitta C, Kim B, Karamcheti S, Baker BH, Saito K, Yasuda Y, Patil D, Briganti A, Salonia A, Fujii Y, Master V, Montorsi F, Derweesh IH. Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis. Clin Genitourin Cancer. 2026 Feb; 24(1):102460.
-
Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Puri D, Dabbas M, Birouty N, Karamcheti S, Kim B, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Saita A, Lazzeri M, Lughezzani G, Casale P, Buffi NM, Derweesh IH. Rising Trends of Aggressive Renal Cell Carcinoma Among Younger Adults: Insights From the National Cancer Database. Clin Genitourin Cancer. 2025 Dec; 23(6):102425.
-
Musso G, Garofano G, Dabbas M, Meagher MF, Yuen KL, Birouty N, Baker B, Saitta C, Guer M, Montorsi F, Briganti A, Capitanio U, Larcher A, Salonia A, Derweesh IH. The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based Study. Clin Genitourin Cancer. 2025 Oct; 23(5):102412.
-
Musso G, Birouty N, Salonia A, Garofano G, Dabbas M, Meagher MF, Yuen KL, Baker B, Saitta C, Patil D, Tanaka H, Kobayashi M, Fukuda S, Montorsi F, Briganti A, Capitanio U, Larcher A, Rosiello G, Fujii Y, Master VA, Derweesh IH. Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025 Nov; 205:99-107.
-
Saitta C, Garofano G, Musso G, Tanaka H, Patil D, Nguyen V, Yuen KL, Baker B, Dabbas M, Meagher MF, Puri D, Birouty N, Baker O, Kobayashi M, Fukuda S, Paciotti M, Lughezzani G, Larcher A, Capitanio U, Melloni R, Catanzaro M, Nazzani S, Nicolai N, Fujii Y, Master V, Buffi N, Derweesh IH. UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion. World J Urol. 2025 Jun 04; 43(1):355.
-
Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Puri D, Dabbas M, Birouty N, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Lughezzani G, Casale P, Buffi NM, Derweesh IH. Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablation. Urol Oncol. 2025 Sep; 43(9):524.e9-524.e16.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|